IT1110007B - Derivati della tienoidantoina ad azione terapeutica - Google Patents
Derivati della tienoidantoina ad azione terapeuticaInfo
- Publication number
- IT1110007B IT1110007B IT19369/79A IT1936979A IT1110007B IT 1110007 B IT1110007 B IT 1110007B IT 19369/79 A IT19369/79 A IT 19369/79A IT 1936979 A IT1936979 A IT 1936979A IT 1110007 B IT1110007 B IT 1110007B
- Authority
- IT
- Italy
- Prior art keywords
- therapeutic action
- therapy therapeutic
- derivatives
- action derivatives
- therapy
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/28—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Ophthalmology & Optometry (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/870,542 US4127665A (en) | 1978-01-18 | 1978-01-18 | Thienohydantoin derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
IT7919369A0 IT7919369A0 (it) | 1979-01-17 |
IT1110007B true IT1110007B (it) | 1985-12-23 |
Family
ID=25355609
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT19369/79A IT1110007B (it) | 1978-01-18 | 1979-01-17 | Derivati della tienoidantoina ad azione terapeutica |
Country Status (11)
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4147797A (en) * | 1978-08-11 | 1979-04-03 | Pfizer Inc. | Spiro-furanohydantoin derivatives |
US4181728A (en) * | 1978-11-16 | 1980-01-01 | Pfizer Inc. | Spiro-polycyclicimidazolidinedione derivatives |
US4181729A (en) * | 1979-03-21 | 1980-01-01 | Pfizer Inc. | Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives |
US4210667A (en) * | 1979-04-19 | 1980-07-01 | Pfizer Inc. | Pharmaceutical preparations containing coumarin carboxylic acid derivatives |
US4490381A (en) * | 1979-11-13 | 1984-12-25 | Imperial Chemical Industries Plc | 1'-Substituted spiro[imidazolidine-4,3'-indoline]2,2',5-triones |
DE3261684D1 (en) * | 1981-05-12 | 1985-02-07 | Ici Plc | Pyrrole derivatives |
US4436745A (en) | 1982-04-15 | 1984-03-13 | Alcon Laboratories, Inc. | Method of inhibiting aldose reductase activity |
US4464385A (en) * | 1982-04-15 | 1984-08-07 | Alcon Laboratories, Inc. | Treatment of diabetic complications with hydantoins |
US4540700A (en) * | 1982-04-15 | 1985-09-10 | Alcon Laboratories, Inc. | Treatment of diabetic complications with certain spiro-imidazolidine-diones |
US4438272A (en) | 1982-04-15 | 1984-03-20 | Alcon Laboratories, Inc. | Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones |
US4537892A (en) * | 1983-09-14 | 1985-08-27 | Alcon Laboratories, Inc. | Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase |
US5070100A (en) * | 1983-09-14 | 1991-12-03 | Alcon Laboratories, Inc. | Spiro-tricyclicaromatic succinimide derivatives |
US4864028A (en) * | 1983-09-14 | 1989-09-05 | Alcon Laboratories, Inc. | Spiro-tricyclicaromatic succinimide derivatives |
US5153211A (en) * | 1983-09-14 | 1992-10-06 | Alcon Laboratories, Inc. | Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase |
US4680306A (en) * | 1984-07-20 | 1987-07-14 | Pfizer Inc. | Sprio-imidazolones for treatment of diabetes complications |
US4966911A (en) * | 1984-11-20 | 1990-10-30 | Washington Research Foundation | Immunoregulatory agents |
US5340829A (en) * | 1984-11-20 | 1994-08-23 | Washington Research Foundation | Immunoregulatory agents |
JP2708507B2 (ja) * | 1988-04-07 | 1998-02-04 | 株式会社三和化学研究所 | (d)‐6‐フルオロ‐2,3‐ジヒドロ‐2’,5’‐ジオキソ‐スピロ[4H‐1‐ベンゾピラン‐4,4’‐イミダゾリジン]‐2‐カルボキサミド誘導体、これらの製法及び用途 |
JPH05508386A (ja) * | 1989-02-10 | 1993-11-25 | ワシントン リサーチ ファンデション | 免疫調整剤 |
KR101772834B1 (ko) | 2009-12-04 | 2017-08-29 | 선오비온 파마슈티컬스 인코포레이티드 | 다환형 화합물 및 이의 사용 방법 |
HRP20241631T1 (hr) | 2016-07-29 | 2025-02-28 | Sumitomo Pharma America, Inc. | Spojevi i pripravci i njihove uporabe |
CN110087687A (zh) | 2016-07-29 | 2019-08-02 | 赛诺维信制药公司 | 化合物、组合物及其用途 |
IL303177A (en) | 2017-02-16 | 2023-07-01 | Sunovion Pharmaceuticals Inc | Treatment of schizophrenia |
BR112020001433A2 (pt) | 2017-08-02 | 2020-07-28 | Sunovion Pharmaceuticals Inc. | compostos de isocromano e usos dos mesmos |
KR102746817B1 (ko) | 2018-02-16 | 2024-12-24 | 스미토모 파마 아메리카, 인크. | 염, 결정 형태 및 이들의 제조 방법 |
WO2020186165A1 (en) | 2019-03-14 | 2020-09-17 | Sunovion Pharmaceuticals Inc. | Salts of a isochromanyl compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof |
JP2023523569A (ja) | 2020-04-14 | 2023-06-06 | サノビオン ファーマシューティカルズ インク | 神経学的および精神障害の治療方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB796069A (en) * | 1955-12-23 | 1958-06-04 | Ici Ltd | Substituted hydantoins |
DE1135915B (de) * | 1961-06-29 | 1962-09-06 | Asta Werke Ag Chem Fab | Verfahren zur Herstellung neuer, antikonvulsiv wirksamer Spirohydantoine |
CA1088945A (en) * | 1976-10-18 | 1980-11-04 | Pfizer Limited | Hydantoin derivatives as therapeutic agents |
-
1978
- 1978-01-18 US US05/870,542 patent/US4127665A/en not_active Expired - Lifetime
-
1979
- 1979-01-16 BE BE0/192915A patent/BE873500A/xx not_active IP Right Cessation
- 1979-01-16 DE DE2901477A patent/DE2901477C2/de not_active Expired
- 1979-01-16 LU LU80795A patent/LU80795A1/xx unknown
- 1979-01-17 JP JP444379A patent/JPS54109975A/ja active Granted
- 1979-01-17 FR FR7901155A patent/FR2415112A1/fr active Granted
- 1979-01-17 IT IT19369/79A patent/IT1110007B/it active
- 1979-01-17 DK DK019579A patent/DK151260C/da not_active IP Right Cessation
- 1979-01-17 NL NLAANVRAGE7900354,A patent/NL176459B/xx not_active IP Right Cessation
- 1979-01-17 GB GB791692A patent/GB2012759B/en not_active Expired
- 1979-01-30 IE IE88/79A patent/IE47726B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
NL176459B (nl) | 1984-11-16 |
FR2415112B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1983-01-14 |
NL7900354A (nl) | 1979-07-20 |
FR2415112A1 (fr) | 1979-08-17 |
LU80795A1 (fr) | 1979-09-07 |
IE790088L (en) | 1979-07-18 |
GB2012759A (en) | 1979-08-01 |
US4127665A (en) | 1978-11-28 |
DK19579A (da) | 1979-07-19 |
BE873500A (fr) | 1979-07-16 |
DE2901477A1 (de) | 1979-07-19 |
DK151260B (da) | 1987-11-16 |
IE47726B1 (en) | 1984-05-30 |
JPS612067B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1986-01-22 |
JPS54109975A (en) | 1979-08-29 |
DE2901477C2 (de) | 1982-06-09 |
GB2012759B (en) | 1982-05-26 |
DK151260C (da) | 1988-05-09 |
IT7919369A0 (it) | 1979-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT1110007B (it) | Derivati della tienoidantoina ad azione terapeutica | |
IT1148727B (it) | Derivati di 4-fenil-ftalazine ad azione terapeutica | |
FI781613A7 (fi) | Terapeutiska hydantoinfoereningar | |
IT8112604A0 (it) | Scarpa terapeutica | |
FI781614A7 (fi) | Terapeutiska aemnen | |
DK32982A (da) | Terapeutisk nyttige tetralinderivater | |
DK302276A (da) | Terapeutisk strompe | |
IS2443A7 (is) | thekjuefni til lækninga | |
FR2333488A1 (fr) | Implant phallique | |
SE7807416L (sv) | Terapeutisk strumpa | |
IT1106176B (it) | Derivati di pirrolo loro procedimento di preparazione e loro applicazione terapeutica | |
FI783326A7 (fi) | Terapeutiska aemnen | |
DK146151C (da) | Invalidestol | |
IT1110097B (it) | Derivati della cumarina | |
IT1110751B (it) | Derivati della prostaglandina | |
IT1114222B (it) | Derivati 4-ammino-2-piperidinochinazolinici ad azione terapeutica | |
FR2320724A1 (fr) | Structure implantable | |
IT1193842B (it) | Derivati della cisteina | |
FI780738A7 (fi) | Framstaellning av terapeutiska medel | |
SE7809887L (sv) | Terapeutiska medel | |
LU81107A1 (fr) | Agents therapeutiques | |
FI784057A7 (fi) | Massasil | |
IT1094287B (it) | Derivati della 2-idrossimetil-pirazina aventi attivita' ipolipemizzante | |
IT1114249B (it) | Derivato della tetraidro-isochinolina | |
IT1107844B (it) | Derivati della benzammidina procedimento per la loro preparazione e loro impiego terapeutico |